These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12728848)

  • 21. Enfuvirtide, a new treatment for HIV infection.
    Moledina S; Boucher M
    Issues Emerg Health Technol; 2003 Oct; (50):1-6. PubMed ID: 14594020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanded distribution for enfuvirtide.
    AIDS Patient Care STDS; 2004 Jun; 18(6):366. PubMed ID: 15384197
    [No Abstract]   [Full Text] [Related]  

  • 23. Pentafuside shows anti-HIV activity.
    AIDS Patient Care STDS; 1996 Jun; 10(3):184. PubMed ID: 11361624
    [No Abstract]   [Full Text] [Related]  

  • 24. What's taking T-20 so long?
    Huff B
    GMHC Treat Issues; 2001 Apr; 15(4):1-3. PubMed ID: 11590938
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA notifications. FDA approves Fuzeon, the first fusion inhibitor.
    AIDS Alert; 2003 Jun; 18(6):78-9. PubMed ID: 12866478
    [No Abstract]   [Full Text] [Related]  

  • 26. Man of the Year. Hope with an asterisk.
    Lacayo R
    Time; 1996 Dec 30-1997 Jan 6; 148(29):82-5. PubMed ID: 10163846
    [No Abstract]   [Full Text] [Related]  

  • 27. Enfuvirtide (Fuzeon): the first fusion inhibitor.
    Williams IG
    Int J Clin Pract; 2003 Dec; 57(10):890-7. PubMed ID: 14712892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging drugs in the fight against HIV disease.
    Rosenthal E
    HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497
    [No Abstract]   [Full Text] [Related]  

  • 29. New class of medications approved for advance HIV.
    FDA Consum; 2003; 37(3):5. PubMed ID: 12793380
    [No Abstract]   [Full Text] [Related]  

  • 30. Shape-shifting: the art of drug pricing.
    Proj Inf Perspect; 2007 Oct; (44):4-8. PubMed ID: 18046832
    [No Abstract]   [Full Text] [Related]  

  • 31. Abacavir's trials and tribulations.
    Gilden D
    GMHC Treat Issues; 1998 Nov; 12(11):1-3. PubMed ID: 11365905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thousands face loss of treatment in ADAP money crisis.
    Krauss K
    AIDS Treat News; 2002 Jun; (381):5-8, 1. PubMed ID: 12161858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV drugs. FDA new drug approval rate lowest in 10 years.
    AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17323437
    [No Abstract]   [Full Text] [Related]  

  • 34. New atazanavir capsule approved.
    AIDS Patient Care STDS; 2006 Nov; 20(11):813. PubMed ID: 17134355
    [No Abstract]   [Full Text] [Related]  

  • 35. Fuzeon data review.
    GMHC Treat Issues; 2003 Mar; 17(3):6. PubMed ID: 12728857
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA notifications. Tentative approval granted for combo antiretroviral drug.
    AIDS Alert; 2007 Oct; 22(10):117-8. PubMed ID: 18416009
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV pre-exposure prophylaxis.
    Morin SF; Yamey G; Rutherford GW
    BMJ; 2012 Aug; 345():e5412. PubMed ID: 22890030
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA regulations. FDA shuts down sale of unregulated HIV drug.
    AIDS Policy Law; 2004 Sep; 19(18):8. PubMed ID: 18680858
    [No Abstract]   [Full Text] [Related]  

  • 39. An overview of the drug approval process.
    Martinez LJ
    Res Initiat Treat Action; 2002; 8(1):11-7. PubMed ID: 12489521
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA approves two combination pills, Epzicom and Truvada; comment on commercial race to once-a-day nucleosides.
    James JS
    AIDS Treat News; 2004 Jul; (403):6. PubMed ID: 15386855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.